Clinical Trial Update: Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

This clinical trial update discusses a Phase 2 study evaluating the efficacy and safety of treprostinil in patients with intermediate-risk pulmonary arterial hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Pulmonary Arterial Hypertension (PAH) | Phase 2 | Status: NOT_YET_RECRUITING